Saturday 17 October 2026
Export BMRA’s income statement to Excel — free account
Biomerica, Inc.
BMRA Healthcare Medical Devices
Biomerica, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $4.5 million, down 16.2% from fiscal 2025. In the quarter to May 2026, revenue grew 17.0%, EPS grew 37.8% and free cash flow fell 35.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
1.85
0.03
−1.60%
Follow BMRA
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 4 | 6 |
+8 more TTM periods Free account |
| (112.10%) | (94.32%) | (84.30%) | (69.61%) | ||
| (59.43%) | (68.12%) | (60.49%) | (49.65%) | ||
ROIC |
(251.51%) | (168.95%) | (173.99%) | (145.31%) | |
Return on Tangible Assets |
(234.04%) | (157.33%) | (108.87%) | (84.49%) | |
Average Days of Receivables |
64.34 | 79.40 | 77.54 | 90.05 | |
Free Cash Flow per Share |
(1.18) | (1.07) | (1.02) | (1.05) | |
Free Cash Flow |
(3.43) | (3.23) | (2.97) | (2.77) | |
Capital Expenditures |
0.00 | (0.06) | — | — | |
| Other line items | |||||
Cash ROIC |
(87.00%) | (69.35%) | (42.51%) | (33.70%) | |
Accounts Receivable Turnover |
5.87 | 3.92 | 3.92 | 3.54 | |
Accounts Payable Turnover |
4.44 | 6.08 | 5.30 | 4.80 | |
Inventory Turnover |
2.56 | 2.51 | 2.54 | 2.49 | |
Average Days of Payables |
104.48 | 64.33 | 64.14 | 58.47 | |
Days of Inventory on Hand |
152.30 | 144.96 | 132.10 | 126.47 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
17.70% | 19.30% | 19.61% | 19.21% | |
Selling, General and Administrative Expense of Revenue |
109.90% | 108.74% | 104.08% | 93.82% | |
Share Based Compensation of Revenue |
10.69% | 11.40% | 10.72% | 10.57% | |
Operating CF/Net income |
0.91 | 0.76 | 0.74 | 0.76 | |
Depreciation/Fixed assets |
5.40 | 4.55 | 3.89 | 3.38 | |
Capex/Depreciation |
(0.01) | (0.14) | 0.00 | 0.00 | |
Revenue per Share |
1.53 | 1.44 | 1.53 | 1.85 | |
Operating CF per Share |
(1.17) | (1.05) | (1.02) | (1.05) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.00 |
Columns are period end dates